FDA Inspection 795285 — Center for Reproductive Medicine

Center for Reproductive Medicine — FEI 3005950704

The FDA completed an inspection of Center for Reproductive Medicine on August 6, 2012 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 6, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Minneapolis, MN (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures